HC Wainwright Reaffirms Buy Rating for Kura Oncology (NASDAQ:KURA)

HC Wainwright reiterated their buy rating on shares of Kura Oncology (NASDAQ:KURA – Free Report) in a research report released on Wednesday morning, Benzinga reports. HC Wainwright currently has a $32.00 target price on the stock. Other equities research analysts have also recently issued research reports about the stock. StockNews.com cut shares of Kura Oncology […]

Related Keywords

United States ,Troy Edward Wilson ,Thomas James Doyle ,Kura Oncology Inc ,Blackrock Inc ,Deerfield Management Companylp Series ,Kura Oncology ,Free Report ,Moderate Buy ,Get Free Report ,James Doyle ,Edward Wilson ,Street Corp ,Lysinek Specific Methyltransferase ,Kura Oncology Daily ,